市場調查報告書
商品編碼
1059560

青光眼手術器械的全球市場增長機會/行業預測(2021-2030 年):按手術類型/產品/最終用戶(眼科醫院和眼科診所/急診手術中心/門診手術中心)

Glaucoma Surgery Devices Market by Surgery Type, Product, and End User (Eye Hospital & Ophthalmology Clinic, Ambulatory Surgical Centers, and Outpatient Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030.

出版日期: | 出版商: Allied Market Research | 英文 224 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球青光眼手術器械市場預計將從 2020 年的 8.1846 億美元增長到預測期內的 24.60% 的複合年增長率,並在 2030 年增長到 651.407 萬美元。

推動青光眼手術器械市場增長的因素包括青光眼患病率的增加和易患眼部疾病的老年人口的增加。對微創青光眼手術 (MIGS) 的需求增加和青光眼手術設備的技術進步也在推動市場增長。另一方面,MIGS 設備的報銷障礙以及與青光眼手術相關的術後併發症風險正在阻礙市場的進一步增長。此外,低收入國家缺乏合格的青光眼手術專家和眼科護理意識低下,預計也將抑制市場增長。

本報告調查了全球青光眼手術器械市場、市場定義和概況、市場影響因素分析、市場規模轉型/預測、手術類型/產品/最終用戶/地區/主要國家等。按類別細分、競爭環境、主要公司概況等匯總。

目錄

第一章介紹

第2章執行摘要

第三章市場概述

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 各大公司的定位
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 影響分析
  • COVID-19 的影響分析

第 4 章青光眼手術器械市場:按手術類型

  • 概覽
  • 傳統青光眼手術
  • 微創青光眼手術 (MIGS)
    • 主要市場趨勢/增長因素/機會
    • 市場規模/預測
    • 市場分析:按國家/地區

第 5 章青光眼手術器械市場:按產品分類

  • 概覽
  • 植入物和支架
  • 青光眼引流器
  • 青光眼激光儀
    • 市場規模/預測:按地區
    • 市場分析:按國家/地區

第 6 章青光眼手術設備市場:按最終用戶分類

  • 概覽
  • 眼科醫院及眼科診所
  • 急診外科中心
  • 門診手術中心
    • 市場規模/預測
    • 市場分析:按國家/地區

第 7 章青光眼手術器械市場:按地區劃分

  • 概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢/增長因素/機會
    • 市場規模/預測:按國家/地區
    • 市場規模/預測:按手術類型
    • 市場規模/預測:按產品分類
    • 市場規模/預測:按最終用戶

第 8 章公司簡介

  • ABBVIE INC.(ALLERGAN)
  • ALCON INC.
  • GLAUKOS CORPORATION
  • JOHNSON & JOHNSON(ABBOTT MEDICAL OPTICS)
  • ISTAR MEDICAL SA
  • LUMIBIRD MEDICAL(ELLEX MEDICAL LASERS LTD)
  • LUMENIS LTD.
  • NEW WORLD MEDICAL, INC
  • SANTEN PHARMACEUTICAL CO. LTD.
  • TOPCON CORPORATION
目錄
Product Code: LI_172950 / A02613

The global glaucoma surgery devices market was valued at $818.46 million in 2020 and is projected to reach $6514.07 million by 2030 registering a CAGR of 24.60% from 2021 to 2030.

Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of eye called the optic nerve. It is the progressive loss of retinal ganglion cells and is associated with a characteristic optic neuropathy and visual field loss. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may result in loss of vision permanently. The aim of glaucoma surgery is to lower eye pressure to prevent or reduce damage to the optic nerve with the use of glaucoma surgery devices. Glaucoma surgery devices such as stents, shunts, and micro implants are utilized for treatment of patients with mild-to-moderate glaucoma.

The factors that drive growth of the glaucoma surgery devices market include rise in prevalence of glaucoma, coupled with growth in geriatric population which are more prone to eye disease. In addition, increase in demand for minimal invasive glaucoma surgery (MIGS) procedures, and technological advancements in glaucoma surgery devices further boost growth of the glaucoma surgery devices market. However, reimbursement barriers regarding MIGS devices and risk of post-operative complications associated with glaucoma surgeries hamper growth of the market. Furthermore, lack of adequate skilled professionals to perform glaucoma surgeries, coupled with lack of awareness about eye care in low-income economies is also expected to limit growth of the market. In contrast, programs and initiatives to reduce burden of glaucoma across the globe and high growth potential in untapped emerging economies are some factors expected to offer lucrative growth opportunities for players in the glaucoma surgery devices market.

The global glaucoma surgery devices market is segmented on the basis of surgery type, product, end user, and region to provide a detailed assessment of the market. By surgery type, it is segmented into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. By product, the market is segmented into implants & stents, glaucoma drainage devices, and glaucoma laser devices. By end user, it is categorized into eye hospital & ophthalmology clinic, ambulatory surgical centers (ASCS), and outpatient surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the glaucoma surgery devices market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of glaucoma surgery devices used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

By Product

  • Implants & Stents
  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices

By End User

  • Eye Hospital & Ophthalmology Clinic
  • Ambulatory Surgical Centers (ASCS)
  • Outpatient Surgical Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • ABBVIE INC. (ALLERGAN)
  • ALCON INC
  • GLAUKOS CORPORATION
  • JOHNSON & JOHNSON (ABBOTT MEDICAL OPTICS)
  • ISTAR MEDICAL SA
  • LUMIBIRD MEDICAL (ELLEX MEDICAL LASERS LTD)
  • LUMENIS LTD
  • NEW WORLD MEDICAL, INC
  • SANTEN PHARMACEUTICAL CO. LTD
  • TOPCON CORPORATION

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Rise in prevalence of glaucoma, coupled with growth in geriatric population
      • 3.5.1.2.Increase in demand for minimally invasive glaucoma surgery (MIGS) procedures
      • 3.5.1.3.Technological advancements in glaucoma surgery devices
    • 3.5.2.Restraints
      • 3.5.2.1.Reimbursement barriers regarding MIGS devices
      • 3.5.2.2.Lack of adequate skilled professionals, coupled with lack of awareness about eye care in low-income economies
      • 3.5.2.3.Risk of post-operative complications associated with glaucoma surgeries
    • 3.5.3.Opportunities
      • 3.5.3.1.Programs and initiatives to reduce burden of glaucoma across the globe
      • 3.5.3.2.High growth potential in untapped emerging economies
    • 3.5.4.Impact analysis
  • 3.6.COVID-19 Impact analysis on the glaucoma surgery devices market

CHAPTER 4:GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Conventional glaucoma surgeries
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Minimally Invasive glaucoma surgeries
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country

CHAPTER 5:GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Implants & stents
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Glaucoma drainage devices
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Glaucoma laser devices
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country

CHAPTER 6:GLAUCOMA SURGERY DEVICES MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Eye hospitals & ophthalmology clinic
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Ambulatory surgical centers (ASCs)
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Outpatient surgical centers
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country

CHAPTER 7:GLAUCOMA SURGERY DEVICES MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
      • 7.2.2.1.U.S.
      • 7.2.2.1.1.U.S. glaucoma surgery devices market, by surgery type
      • 7.2.2.1.2.U.S. glaucoma surgery devices market, by product
      • 7.2.2.1.3.U.S. glaucoma surgery devices market, by end user
      • 7.2.2.2.Canada
      • 7.2.2.2.1.Canada glaucoma surgery devices market, by surgery type
      • 7.2.2.2.2.Canada glaucoma surgery devices market, by product
      • 7.2.2.2.3.Canada glaucoma surgery devices market, by end user
      • 7.2.2.3.Mexico
      • 7.2.2.3.1.Mexico glaucoma surgery devices market, by surgery type
      • 7.2.2.3.2.Mexico glaucoma surgery devices market, by product
      • 7.2.2.3.3.Mexico glaucoma surgery devices market, by end user
    • 7.2.3.North America market size and forecast, by surgery type
    • 7.2.4.North America market size and forecast, by product
    • 7.2.5.North America market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany glaucoma surgery devices market, by surgery type
      • 7.3.2.1.2.Germany glaucoma surgery devices market, by product
      • 7.3.2.1.3.Germany glaucoma surgery devices market, by end user
      • 7.3.2.2.France
      • 7.3.2.2.1.France glaucoma surgery devices market, by surgery type
      • 7.3.2.2.2.France glaucoma surgery devices market, by product
      • 7.3.2.2.3.France glaucoma surgery devices market, by end user
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK glaucoma surgery devices market, by surgery type
      • 7.3.2.3.2.UK glaucoma surgery devices market, by product
      • 7.3.2.3.3.UK glaucoma surgery devices market, by end user
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy glaucoma surgery devices market, by surgery type
      • 7.3.2.4.2.Italy glaucoma surgery devices market, by product
      • 7.3.2.4.3.Italy glaucoma surgery devices market, by end user
      • 7.3.2.5.Spain
      • 7.3.2.5.1.Spain glaucoma surgery devices market, by surgery type
      • 7.3.2.5.2.Spain glaucoma surgery devices market, by product
      • 7.3.2.5.3.Spain glaucoma surgery devices market, by end user
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe glaucoma surgery devices market, by surgery type
      • 7.3.2.6.2.Rest of Europe glaucoma surgery devices market, by product
      • 7.3.2.6.3.Rest of Europe glaucoma surgery devices market, by end user
    • 7.3.3.Europe market size and forecast, by surgery type
    • 7.3.4.Europe market size and forecast, by product
    • 7.3.5.Europe market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan glaucoma surgery devices market, by surgery type
      • 7.4.2.1.2.Japan glaucoma surgery devices market, by product
      • 7.4.2.1.3.Japan glaucoma surgery devices market, by end user
      • 7.4.2.2.China
      • 7.4.2.2.1.China glaucoma surgery devices market, by surgery type
      • 7.4.2.2.2.China glaucoma surgery devices market, by product
      • 7.4.2.2.3.China glaucoma surgery devices market, by end user
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia glaucoma surgery devices market, by surgery type
      • 7.4.2.3.2.Australia glaucoma surgery devices market, by product
      • 7.4.2.3.3.Australia glaucoma surgery devices market, by end user
      • 7.4.2.4.India
      • 7.4.2.4.1.India glaucoma surgery devices market, by surgery type
      • 7.4.2.4.2.India glaucoma surgery devices market, by product
      • 7.4.2.4.3.India glaucoma surgery devices market, by end user
      • 7.4.2.5.South Korea
      • 7.4.2.5.1.South Korea glaucoma surgery devices market, by Surgery type
      • 7.4.2.5.2.South Korea glaucoma surgery devices market, by product
      • 7.4.2.5.3.South Korea glaucoma surgery devices market, by end user
      • 7.4.2.6.Rest of Asia-Pacific
      • 7.4.2.6.1.Rest of Asia-Pacific glaucoma surgery devices market, by surgery type
      • 7.4.2.6.2.Rest of Asia-Pacific glaucoma surgery devices market, by product
      • 7.4.2.6.3.Rest of Asia-Pacific glaucoma surgery devices market, by end user
    • 7.4.3.Asia-Pacific market size and forecast, by surgery type
    • 7.4.4.Asia-Pacific market size and forecast, by product
    • 7.4.5.Asia-Pacific market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil
      • 7.5.2.1.1.Brazil glaucoma surgery devices market, by surgery type
      • 7.5.2.1.2.Brazil glaucoma surgery devices market, by product
      • 7.5.2.1.3.Brazil glaucoma surgery devices market, by end user
      • 7.5.2.2.Turkey
      • 7.5.2.2.1.Turkey glaucoma surgery devices market, by surgery type
      • 7.5.2.2.2.Turkey glaucoma surgery devices market, by product
      • 7.5.2.2.3.Turkey glaucoma surgery devices market, by end user
      • 7.5.2.3.Saudi Arabia
      • 7.5.2.3.1.Saudi Arabia glaucoma surgery devices market, by surgery type
      • 7.5.2.3.2.Saudi Arabia glaucoma surgery devices market, by product
      • 7.5.2.3.3.Saudi Arabia glaucoma surgery devices market, by end user
      • 7.5.2.4.South Africa
      • 7.5.2.4.1.South Africa glaucoma surgery devices market, by surgery type
      • 7.5.2.4.2.South Africa glaucoma surgery devices market, by product
      • 7.5.2.4.3.South Africa glaucoma surgery devices market, by end user
      • 7.5.2.5.Rest of LAMEA
      • 7.5.2.5.1.Rest of LAMEA glaucoma surgery devices market, by surgery type
      • 7.5.2.5.2.Rest of LAMEA glaucoma surgery devices market, by product
      • 7.5.2.5.3.Rest of LAMEA glaucoma surgery devices market, by end user
    • 7.5.3.LAMEA market size and forecast, by surgery type
    • 7.5.4.LAMEA market size and forecast, by product
    • 7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.ABBVIE INC. (ALLERGAN)
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.ALCON INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.GLAUKOS CORPORATION
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.JOHNSON & JOHNSON (ABBOTT MEDICAL OPTICS)
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
  • 8.5.ISTAR MEDICAL SA
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Key strategic moves and developments
  • 8.6.LUMIBIRD MEDICAL (ELLEX MEDICAL LASERS LTD)
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.LUMENIS LTD.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Key strategic moves and developments
  • 8.8.NEW WORLD MEDICAL, INC
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Key strategic moves and developments
  • 8.9.SANTEN PHARMACEUTICAL CO. LTD.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
  • 8.10.TOPCON CORPORATION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 02.GLAUCOMA SURGERY DEVICES MARKET FOR CONVENTIONAL GLAUCOMA SURGERIES, BY REGION, 2020-2030($MILLION)
  • TABLE 03.GLAUCOMA SURGERY DEVICES MARKET FOR MINIMALLY INVASIVE GLAUCOMA SURGERIES, BY REGION, 2020-2030($MILLION)
  • TABLE 04.GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 05.GLAUCOMA SURGERY DEVICES MARKET FOR IMPLANTS & STENTS, BY REGION, 2020-2030($MILLION)
  • TABLE 06.GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA DRAINAGE DEVICES, BY REGION, 2020-2030($MILLION)
  • TABLE 07.GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA LASER DEVICES, BY REGION, 2020-2030($MILLION)
  • TABLE 08.GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 09.GLAUCOMA SURGERY DEVICES MARKET FOR EYE HOSPITALS & OPHTHALMOLOGY CLINIC, BY REGION, 2020-2030($MILLION)
  • TABLE 10.GLAUCOMA SURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2020-2030($MILLION)
  • TABLE 11.GLAUCOMA SURGERY DEVICES MARKET FOR OUTPATIENT SURGICAL CENTERS, BY REGION, 2020-2030($MILLION)
  • TABLE 12.GLAUCOMA SURGERY DEVICES MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 13.NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 14.U.S. GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 15.U.S. GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 16.U.S. GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 17.CANADA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 18.CANADA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 19.CANADA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 20.MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 21.MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 22.MEXICO GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 23.NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 24.NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 25.NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 26.EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 27.GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 28.GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 29.GERMANY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 30.FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 31.FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 32.FRANCE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 33.UK GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 34.UK GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 35.UK GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 36.ITALY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 37.ITALY GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 38.ITALY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 39.SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 40.SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 41.SPAIN GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 42.REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 43.REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 44.REST OF EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 45.EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 46.EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 47.EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 48.ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 49.JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 50.JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 51.JAPAN GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 52.CHINA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 53.CHINA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 54.CHINA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 55.AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 56.AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 57.AUSTRALIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 58.INDIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 59.INDIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 60.INDIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 61.SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 62.SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 63.SOUTH KOREA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 64.REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 65.REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 66.REST OF ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 67.ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 68.ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 69.ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 70.LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 71.BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 72.BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 73.BRAZIL GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 74.TURKEY GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 75.TURKEY SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 76.TURKEY GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 77.SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 78.SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 79.SAUDI ARABIA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 80.SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 81.SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 82.SOUTH AFRICA GLAUCOMA SURGERY DEVICES MARKET, BY END USER 2020-2030($MILLION)
  • TABLE 83.REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 84.REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 85.REST OF LAMEA GLAUCOMA SURGERY DEVICES MARKET, END USER, 2020-2030($MILLION)
  • TABLE 86.LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2030($MILLION)
  • TABLE 87.LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT, 2020-2030($MILLION)
  • TABLE 88.LAMEA GLAUCOMA SURGERY DEVICES MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 89.ABBVIE: COMPANY SNAPSHOT
  • TABLE 90.ABBVIE: OPERATING SEGMENTS
  • TABLE 91.ABBVIE: PRODUCT PORTFOLIO
  • TABLE 92.ALCON INC.: COMPANY SNAPSHOT
  • TABLE 93.ALCON INC.: OPERATING SEGMENTS
  • TABLE 94.ALCON INC.: PRODUCT PORTFOLIO
  • TABLE 95.ALCON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96.GLAUKOS: COMPANY SNAPSHOT
  • TABLE 97.GLAUKOS: OPERATING SEGMENTS
  • TABLE 98.GLAUKOS: PRODUCT PORTFOLIO
  • TABLE 99.J&J: COMPANY SNAPSHOT
  • TABLE 100.J&J: OPERATING SEGMENTS
  • TABLE 101.J&J: PRODUCT TYPE PORTFOLIO
  • TABLE 102.ISTAR: COMPANY SNAPSHOT
  • TABLE 103.ISTAR: OPERATING SEGMENTS
  • TABLE 104.ISTAR: PRODUCT PORTFOLIO
  • TABLE 105.LUMIBIRD MEDICAL: COMPANY SNAPSHOT
  • TABLE 106.LUMIBIRD MEDICAL: OPERATING SEGMENTS
  • TABLE 107.LUMIBIRD MEDICAL: PRODUCT PORTFOLIO
  • TABLE 108.LUMENIS: COMPANY SNAPSHOT
  • TABLE 109.LUMENIS: OPERATING SEGMENTS
  • TABLE 110.LUMENIS: PRODUCT PORTFOLIO
  • TABLE 111.NEW WORLD MEDICAL: COMPANY SNAPSHOT
  • TABLE 112.NEW WORLD MEDICAL: OPERATING SEGMENTS
  • TABLE 113.NEW WORLD MEDICAL: PRODUCT PORTFOLIO
  • TABLE 114.SANTEN: COMPANY SNAPSHOT
  • TABLE 115.SANTEN: OPERATING SEGMENTS
  • TABLE 116.SANTEN: PRODUCT PORTFOLIO
  • TABLE 117.TOPCON CORPORATION: COMPANY SNAPSHOT
  • TABLE 118.TOPCON CORPORATION: OPERATING SEGMENTS
  • TABLE 119.TOPCON CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10.HIGH INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR CONVENTIONAL GLAUCOMA SURGERIES, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR MINIMALLY INVASIVE GLAUCOMA SURGERIES, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS GLAUCOMA SURGERY DEVICES MARKET FOR IMPLANTS & STENTS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA DRAINAGE DEVICES , BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR GLAUCOMA LASER DEVICES, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR EYE HOSPITALS & OPHTHALMOLOGY CLINIC, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF GLAUCOMA SURGERY DEVICES MARKET FOR OUTPATIENT SURGICAL CENTERS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 21.ABBVIE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 22.ABBVIE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 23.ALCON INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 24.ALCON INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 25.ALCON INC.: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 26.GLAUKOS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 27.GLAUKOS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 28.GLAUKOS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 29.J&J: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 30.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 31.J&J: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 32.LUMIBIRD MEDICAL: NET SALES, 2018-2020, ($MILLION)
  • FIGURE 33.LUMIBIRD MEDICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 34.SANTEN: NET SALES, 2018-2020, ($MILLION)
  • FIGURE 35.TOPCON CORPORATION: NET SALES, 2018-2020, ($MILLION)
  • FIGURE 36.TOPCON CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 37.TOPCON CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)